文献速递泌尿系结石

肾结石治疗的经济毒性:首次评估肾结石治疗的经济压力

Financial Toxicity of Nephrolithiasis: The First Assessment of the Economic Stresses of Kidney Stone Treatment.
PubMed 文献 · Urology · 2022-09-29

本研究为多机构横断面队列研究,纳入241例结石患者(现场126例、在线115例),采用COST量表评估经济毒性。60%报告至少中度经济毒性(COST评分<26),26%报告重度经济毒性(COST评分<14)。自付费用与COST评分呈负相关(Spearman's rho=-0.406,P<.001),中度至重度经济毒性患者及其照护者因结石病缺勤更多(P=.002和P=.007)。

要点

  • 60%的结石患者报告至少中度经济毒性(COST评分<26),26%报告重度经济毒性(COST评分<14)。
  • 自付费用越高,COST评分越低(Spearman's rho=-0.406,P<.001)。
  • 中度至重度经济毒性患者及其照护者因结石病缺勤更多(P=.002和P=.007)。

核心结论

  • 大多数参与者报告中度至重度经济毒性,泌尿外科医生需对接受肾结石治疗患者的经济负担保持敏感。

研究设计与样本

  • 多机构横断面队列研究,纳入241例结石患者,其中现场参与者126例、在线参与者115例,使用经验证的COST工具进行调查。

主要发现

  • 60%的参与者报告至少中度经济毒性(COST评分<26),26%报告重度经济毒性(COST评分<14)。
  • 报告中度至重度经济毒性的患者比低经济毒性患者更年轻,中位差异为8岁(95%CI=4,12)。
  • 自付费用与COST评分呈显著负相关,随着自付费用增加,COST评分降低(Spearman's rho=-0.406,P<.001)。
  • 中度至重度经济毒性参与者因结石病缺勤更多(P=.002),其照护者也因结石病缺勤更多(P=.007)。

关键数值与推荐

  • COST量表最高分为44分,分数越低表示经济毒性越高。
  • 中度经济毒性定义为COST评分在25至14分之间,重度经济毒性定义为COST评分<14分。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the financial toxicity (FT) related to kidney stone treatment. METHODS: We performed a cross-sectional cohort study with multi-institutional in-person and online cohorts of stone formers. Participants were surveyed using the validated COST tool (COmprehensive Score for financial Toxicity). The maximum score is 44 and lower scores indicate increased FT. "Moderate FT" was defined by COST scores between 25 and 14 points and "severe FT" for scores <14. Descriptive statistics, X2 tests, T tests, Spearman correlation, and logistic regression were performed using SPSS v28. RESULTS: Two hundred and forty-one participants were surveyed, including 126 in-person participants and 115 online. A total of 60% of participants reported at least moderate FT (COST score <26) and 26% reported severe FT (COST score <14). Patients who reported moderate to severe FT were younger than those with low FT by a median difference of 8 years (95%CI = 4, 12). There was a significant correlation between out-of-pocket expense and COST scores, such that as out-of-pocket expenses increased, COST scores decreased, (Spearman's rho =-0.406, P = <.001). Participants with moderate to severe FT tended to miss more workdays (P = .002), and their caretakers tended to miss more workdays (P = .007) due to their stone disease. CONCLUSION: Most participants reported moderate to severe FT. As prior studies have shown that patients with "moderate FT" employ cost-coping strategies (i.e., medication rationing) and those with "severe FT" have worse health outcomes, urologists need to be sensitive to the financial burdens of treatment experienced by such patients undergoing kidney stone treatment.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Green BW, Labagnara K, Feiertag N, et al. Financial Toxicity of Nephrolithiasis: The First Assessment of the Economic Stresses of Kidney Stone Treatment. Urology. 2022. PMID: 36183747. doi:10.1016/j.urology.2022.08.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。